<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Reported-in-House" dms-id="H8FDC4799EB6C452185EED76F6C50D49F" public-private="public" bill-type="olc"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HR 2820 RH: Stem Cell Therapeutic and Research Reauthorization Act of 2015</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2015-09-08</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">IB</distribution-code> 
<calendar display="yes">Union Calendar No. 183</calendar>
<congress display="yes">114th CONGRESS</congress> <session display="yes">1st Session</session> 
<legis-num>H. R. 2820</legis-num>
<associated-doc role="report" display="yes">[Report No. 114–242]</associated-doc> 
<current-chamber display="yes">IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20150618">June 18, 2015</action-date> 
<action-desc><sponsor name-id="S000522">Mr. Smith of New Jersey</sponsor> (for himself, <cosponsor name-id="M001163">Ms. Matsui</cosponsor>, <cosponsor name-id="J000296">Mr. Jolly</cosponsor>, and <cosponsor name-id="F000043">Mr. Fattah</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc> 
</action> 
<action>
<action-date date="20150908">September 8, 2015</action-date>
<action-desc>Additional sponsors: <cosponsor name-id="G000551">Mr. Grijalva</cosponsor>, <cosponsor name-id="H001057">Mr. Huelskamp</cosponsor>, <cosponsor name-id="B001257">Mr. Bilirakis</cosponsor>, <cosponsor name-id="M001151">Mr. Murphy of Pennsylvania</cosponsor>, <cosponsor name-id="E000291">Mrs. Ellmers of North Carolina</cosponsor>, <cosponsor name-id="R000580">Mr. Roskam</cosponsor>, <cosponsor name-id="H001052">Mr. Harris</cosponsor>, <cosponsor name-id="D000191">Mr. DeFazio</cosponsor>, <cosponsor name-id="A000055">Mr. Aderholt</cosponsor>, <cosponsor name-id="N000127">Mr. Nolan</cosponsor>, <cosponsor name-id="N000189">Mr. Newhouse</cosponsor>, <cosponsor name-id="R000593">Mr. Ross</cosponsor>, <cosponsor name-id="L000567">Mr. Lance</cosponsor>, <cosponsor name-id="B001269">Mr. Barletta</cosponsor>, <cosponsor name-id="B001248">Mr. Burgess</cosponsor>, <cosponsor name-id="E000215">Ms. Eshoo</cosponsor>, <cosponsor name-id="L000565">Mr. Loebsack</cosponsor>, <cosponsor name-id="H001067">Mr. Hudson</cosponsor>, and <cosponsor name-id="P000597">Ms. Pingree</cosponsor></action-desc>
</action>
<action>
<action-date date="20150908">September 8, 2015</action-date>
<action-desc>Committed to the Committee of the Whole House on the State of the Union and ordered to be printed<pagebreak/></action-desc>
</action>
<legis-type>A BILL</legis-type> 
<official-title display="yes">To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.<pagebreak/></official-title> 
</form> 
<legis-body id="H6AD255E5B3ED423AA4708FA39F8C65A6" style="OLC"> 
<section id="H2D7A386B764F48F997128F54B0168B49" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline"> This Act may be cited as the <quote><short-title>Stem Cell Therapeutic and Research Reauthorization Act of 2015</short-title></quote>.</text></section> <section id="H5847C1D2B49E41A085D5163126A48FBE"><enum>2.</enum><header>Amendments to the Stem Cell Therapeutic and Research Act of 2005</header> <subsection id="HE24F5199EB3143519EE61C1B8FC159DA"><enum>(a)</enum><header>Cord blood inventory</header><text>Section 2 of the Stem Cell Therapeutic and Research Act of 2005 (<external-xref legal-doc="usc" parsable-cite="usc/42/274k">42 U.S.C. 274k</external-xref> note) is amended in subsection (h)—</text> 
<paragraph id="HCD9364FCA30F42AB954B94B5A75BFE67"><enum>(1)</enum><text>in paragraph (1)—</text> <subparagraph id="H9C911F61C6ED4592AFF27CF244ACA537"><enum>(A)</enum><text>by striking <quote>$23,000,000 for each of fiscal years 2011 through 2014 and</quote>; and</text></subparagraph> 
<subparagraph id="H6F9C0964AF6043A4BA7712733428114A"><enum>(B)</enum><text>by inserting before the period at the end the following: <quote>and $23,000,000 for each of fiscal years 2016 through 2020</quote>; and </text> </subparagraph></paragraph> <paragraph id="HFB1C45901DD04427995C20D85CFFD36D"><enum>(2)</enum><text>in paragraph (2), by striking <quote>2011 through 2015</quote> and inserting <quote>2015 through 2020</quote>.</text></paragraph></subsection> 
<subsection id="H23DDDBD38FE8473586DE58521585F3E9" commented="no"><enum>(b)</enum><header>National program</header><text display-inline="yes-display-inline">Section 379B of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/274m">42 U.S.C. 274m</external-xref>) is amended by striking <quote>2011 through 2014</quote> and inserting <quote>2016 through 2020</quote>.</text> </subsection></section> </legis-body> <endorsement display="yes"> <action-date date="20150908">September 8, 2015</action-date> <action-desc>Committed to the Committee of the Whole House on the State of the Union and ordered to be printed</action-desc></endorsement> </bill> 

